Latest News
View All →-
Oct 23, 2026
YolTech Announces Interim Clinical Data from Investigator-Initiated Trials of YOLT-203 in Primary Hyperoxaluria Type 1 to be Presented at the American Society of Nephrology (ASN) Kidney Week 2026
-
Oct 14, 2026
YolTech Appoints Nitin Patel, BM BCh, as U.S. Chief Medical Officer
-
Sep 07, 2026
YolTech Presented Proof-of-Concept Data from Clinical Trial of YOLT-202 in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026
-
Sep 05, 2026
YolTech to Present Late-Breaking Proof-of-Concept Clinical Data from YOLT-202 Clinical Trial in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026
-
Aug 27, 2026
YolTech to Present Positive Data from Clinical Trial of YOLT-201 in ATTR-CM Patients at European Society of Cardiology Congress 2026
Contact
-
Investor Contact
-
Media Contact
